The Claim
Atovaquone inhibits the mitochondrial electron transport chain in Plasmodium falciparum in vitro, while methylene blue and 3-[4-(trifluoromethyl)benzyl]-menadione do not inhibit this chain under the same conditions.
What the research says
Supports is higher
Support is ahead, but a single strong opposing study can change this.
These are independent scores, not a percentage. Higher-grade studies count more, so a single strong opposing study can outweigh several weaker ones.
Atovaquone is a drug that stops a key energy process in the malaria parasite in lab tests, but two other chemicals, methylene blue and another compound, don’t stop it the same way.
See the scientific wording
Atovaquone inhibits the mitochondrial electron transport chain in Plasmodium falciparum in vitro, serving as a positive control in studies testing alternative antimalarial mechanisms, while methylene blue and 3-[4-(trifluoromethyl)benzyl]-menadione do not.
What the research says
1 studyThe study found that atovaquone blocks a key energy process in malaria parasites, while methylene blue and the other chemical do not — so atovaquone is used as a known good test in experiments, but the others work in a different way.
Score breakdown, mechanism chain, raw evidence, ideal studies needed & 1 supporting studies
Not medical advice. For informational purposes only. Always consult a qualified healthcare professional before making health decisions.